Loading...

Edwards Lifesciences Corporation

EWNYSE
Healthcare
Medical - Devices
$77.02
$0.72(0.94%)

Edwards Lifesciences Corporation EW Peers

See (EW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
EW$77.02+0.94%45.1B31.78$2.42N/A
ABT$125.68-0.04%219B15.77$7.98+1.86%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$107.46+4.16%159.5B78.67$1.37N/A
SYK$401.87+1.70%153.2B54.18$7.40+0.83%
MDT$92.20+0.60%117.9B25.49$3.61+3.06%
DXCM$87.07+2.29%33.9B64.98$1.33N/A
PHG$25.86+3.34%23.9B86.18$0.30+3.45%
STE$228.07+1.96%22.2B36.69$6.15+1.01%
PODD$286.05+0.17%20.2B51.75$5.54N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

EW vs ABT Comparison

EW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EW stands at 45.1B. In comparison, ABT has a market cap of 219B. Regarding current trading prices, EW is priced at $77.02, while ABT trades at $125.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EW currently has a P/E ratio of 31.78, whereas ABT's P/E ratio is 15.77. In terms of profitability, EW's ROE is +0.49%, compared to ABT's ROE of +0.32%. Regarding short-term risk, EW is less volatile compared to ABT. This indicates potentially lower risk in terms of short-term price fluctuations for EW.

Stock Price Comparison

Loading...

Frequently Asked Questions

;